IGM Biosciences Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Great. Good afternoon, and thanks for joining us at the Morgan Stanley Global Healthcare Conference. I'm Mike Ulz, the biotech analyst here, and it's my pleasure to introduce Fred Schwarzer, CEO from IGM Biosciences. And just a quick reminder, the format for today is a fireside chat. But if you have questions, please feel free to submit them through the portal, and we will be sure to address them in our discussion.
Just quickly before we get started, I need to read a quick disclaimer for important disclosures. Please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales representative.
So with that, we'll just get right into the Q&A. Fred, thanks for joining us today. Really appreciate it.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |